Skip to main content
. 2021 Feb 19;6:70. doi: 10.1038/s41392-020-00446-7

Fig. 2.

Fig. 2

LncRNA-SLCC1 is clinically relevant in colorectal cancer. a LncSLCC1 mRNA expression in 90 pairs of colorectal cancer and normal tissues in Cohort 2, paired t-test. b Representative images of lncSLCC1 expression in colorectal cancer and adjacent colorectal tissues using ISH analysis in Cohort 3; n = 168. c Summarized data of lncSLCC1 expression in Cohort 3; n = 168. d The overall survival rate was analyzed and compared between patients with high and low levels of lncSLCC1 expression in tumor in Cohort 3; n = 168, log-rank test. e Multivariate cox regression analysis of lncSLCC1 in Cohort 3. f LncSLCC1 mRNA expression in colorectal cancer and adjacent colorectal tissues in TCGA dataset. g Kaplan–Meier curves showing the survival rate of patients with different levels of lncSLCC1 in TCGA dataset. h Comparing different TNM and AJCC stage between lncSLCC1 high- and low-expression tumors in TCGA dataset. The heatmap illustrates the association of different clinical characters with lncSLCC1 high- and low-expression tumors. Statistical significance was performed by the χ2 test